Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 -12.40M
September 30, 2025 -2.052M
June 30, 2025 -0.04M
March 31, 2025 -9.173M
December 31, 2024 -1.356M
September 30, 2024 -2.646M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -2.402M
September 30, 2023 0.00
June 30, 2023 -5.048M
March 31, 2023 0.00
December 31, 2022 -0.002M
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 -21.72M
December 31, 2020 0.00
September 30, 2020 0.006M
June 30, 2020 -7.388M
Date Value
March 31, 2020 -8.562M
December 31, 2019 -0.72M
September 30, 2019 0.00
June 30, 2019 -0.018M
March 31, 2019 -0.043M
December 31, 2018 -13.39M
September 30, 2018 0.068M
June 30, 2018 -4.569M
March 31, 2018 -0.932M
December 31, 2017 -0.366M
September 30, 2017 0.074M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.152M
September 30, 2016 -0.152M
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -0.182M
September 30, 2015 -0.012M
June 30, 2015 -9.237M
March 31, 2015 -0.064M
December 31, 2014 0.03M
September 30, 2014 0.00
June 30, 2014 -1.977M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Imunon, Inc. -3.131M
Agenus, Inc. -14.71M
Amgen, Inc. 0.00
Anika Therapeutics, Inc. 0.643M
BioCryst Pharmaceuticals, Inc. -6.247M